Cumberland Pharmaceutical... (CPIX)
undefined
undefined%
At close: undefined
2.44
1.67%
After-hours Dec 13, 2024, 07:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Revenue 39.55M 42.01M 35.99M 37.44M 34.39M 40.74M 41.15M 33.03M 33.52M 36.90M 32.03M 48.85M 51.14M 45.88M 43.54M 35.08M 28.06M 17.82M 10.69M
Cost of Revenue 6.07M 9.12M 8.81M 8.65M 7.42M 7.38M 7.37M 5.96M 4.97M 5.05M 5.44M 5.05M 5.36M 3.59M 4.14M 3.05M 2.67M 2.40M 533.26K
Gross Profit 33.49M 32.89M 27.17M 28.79M 26.97M 33.36M 33.78M 27.07M 28.55M 31.85M 26.59M 43.81M 45.78M 42.29M 39.40M 32.03M 25.39M 15.42M 10.16M
Operating Income -6.21M -5.70M -7.68M -6.38M -9.29M -7.39M -4.08M -1.43M -1.11M 3.56M -3.80M 8.82M 9.85M 6.50M 5.78M 7.28M 6.73M 2.22M 749.92K
Interest Income 286.85K 98.41K 26.08K 75.34K 243.36K 564.48K 299.33K 204.66K 209.18K 251.45K 230.29K 304.87K 210.73K 200.21K 79.36K 241.28K 382.92K 208.68K 89.24K
Pretax Income -6.28M -5.58M -5.56M -6.57M -9.29M -7.02M -3.87M -1.33M 1.25M 3.74M -3.67M 9.05M 9.71M 5.28M 5.08M 7.31M 6.47M 1.71M 770.32K
Net Income -6.28M -5.65M -5.60M -6.63M -9.21M -6.96M -7.98M -944.68K 731.35K 2.42M -2.10M 5.84M 5.66M 2.46M 3.09M 4.77M 4.04M 4.40M 1.95M
Selling & General & Admin 29.10M 26.84M 24.80M 24.96M 25.25M 30.66M 31.52M 23.12M 21.60M 23.30M 23.88M 29.43M 30.14M 30.66M 27.84M 19.53M 14.19M 10.35M 8.24M
Research & Development 5.83M 6.69M 5.68M 5.77M 6.87M 7.32M 3.90M 3.19M 3.85M 3.39M 5.62M 5.10M 5.03M 4.33M 4.99M 4.43M 3.69M 2.23M 1.16M
Other Expenses 8.10M 5.07M 4.37M 4.43M 4.13M 2.77M 2.44M 2.19M 1.99M 1.60M 896.16K 466.13K 655.30K 686.91K 793.68K 791.11K 783.43K 611.61K 13.49K
Operating Expenses 39.39M 38.60M 34.85M 35.17M 36.26M 40.75M 37.86M 28.50M 27.44M 28.29M 30.39M 34.99M 35.93M 35.79M 33.62M 24.75M 18.67M 13.19M 9.41M
Interest Expense 667.86K 586.00K 98.03K 263.63K 246.19K 195.85K 92.90K 106.39K 73.86K 67.07K 103.42K 71.98K 353.50K 1.42M 772.93K 213.30K 639.59K 721.80K 63.20K
Selling & Marketing Expenses 18.45M 16.66M 15.02M 14.77M 15.28M 20.26M 21.49M 14.55M 13.99M 14.90M 14.39M 20.33M 20.94M 22.67M 20.19M 14.39M 10.05M 7.35M 5.65M
Cost & Expenses 45.46M 47.72M 43.66M 43.82M 43.68M 48.13M 45.23M 34.46M 32.41M 33.34M 35.83M 40.03M 41.29M 39.37M 37.76M 27.79M 21.34M 15.59M 9.94M
Income Tax 45.77K 68.85K 34.89K 55.90K -79.32K 16.64K 4.17M -330.92K 575.83K 1.38M -1.52M 3.24M 4.08M 2.85M 2.02M 2.54M 2.42M -2.70M -1.18M
Shares Outstanding (Basic) 14.30M 14.56M 14.90M 15.16M 15.40M 15.57M 15.91M 15.74M 16.72M 17.62M 18.33M 19.56M 20.34M 20.33M 14.20M 10.14M 10.03M 9.80M 9.50M
Shares Outstanding (Diluted) 14.30M 14.56M 14.90M 15.16M 15.40M 15.61M 15.91M 16.24M 17.09M 17.90M 18.33M 19.79M 20.57M 21.06M 18.23M 16.54M 16.58M 16.45M 16.09M
EPS (Basic) -0.44 -0.39 -0.38 -0.44 -0.6 -0.45 -0.5 -0.06 0.04 0.14 -0.11 0.30 0.28 0.12 0.22 0.47 0.40 0.45 0.21
EPS (Diluted) -0.44 -0.39 -0.38 -0.44 -0.6 -0.45 -0.5 -0.06 0.04 0.14 -0.11 0.30 0.28 0.12 0.17 0.29 0.24 0.27 0.12
EBITDA 153.32K 332.92K -857.83K -1.56M -4.64M -8.19M -1.13M 1.17M 3.57M 5.73M -2.27M 10.02M 11.00M 7.68M 6.67M 8.31M 7.87M 3.02M 882.39K
Depreciation & Amortization 5.77M 5.33M 4.61M 4.75M 4.40M 2.98M 2.65M 2.40M 2.25M 1.99M 1.30M 901.65K 1.04M 978.40K 816.50K 786.60K 762.22K 587.74K 53.54K